Here, this study will provide important theoretical evidence for explaining the mechanisms of the LINC01606–SCD1–Wnt/β‐catenin axis in colon cancer progression and simultaneously provide a new biomarker and target for cancer therapy. Here, SCD is linked to malignant colon neoplasm.